Table 2 Prevalence of SAgs genes in S. aureus isolates from patients of Group 1 and Group 2
SAgs and toxins | Group 1 (n = 160) | Group 2 (n = 190) | MRSA | MSSA | Total in Group 1 | Total in Group 2 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Female | Male | Female | Male | Group 1 | Group 2 | Group 1 | Group 2 | |||
SEA | 5 | 12 | 11 | 14 | 11 | 20 | 6 | 6 | 17 | 26 |
SEB | 1 | 10 | 9 | 10 | 7 | 11 | 4 | 8 | 11 | 19 |
SEC | 3 | 2 | 5 | 16 | 6 | 19 | 0 | 2 | 5 | 21 |
SED | 11 | 2 | 1 | 16 | 9 | 13 | 4 | 7 | 13 | 17 |
SEE | 4 | 11 | 6 | 13 | 6 | 16 | 9 | 3 | 15 | 19 |
SEl-G | 0 | 2 | 8 | 8 | 2 | 11 | 0 | 5 | 2 | 16 |
SEl-H | 1 | 5 | 3 | 13 | 5 | 9 | 1 | 7 | 6 | 16 |
SEI | 4 | 3 | 7 | 13 | 6 | 15 | 1 | 5 | 7 | 20 |
SEl-J | 5 | 6 | 2 | 9 | 7 | 16 | 4 | 2 | 11 | 14 |
SEl-K | 1 | 6 | 1 | 6 | 6 | 11 | 1 | 2 | 7 | 13 |
SEl-L | 4 | 5 | 2 | 7 | 4 | 19 | 5 | 2 | 9 | 21 |
SEl-M | 2 | 9 | 5 | 6 | 10 | 17 | 1 | 9 | 11 | 26 |
SEl-N | 5 | 7 | 5 | 7 | 9 | 11 | 3 | 8 | 12 | 19 |
SEl-O | 9 | 13 | 7 | 15 | 16 | 23 | 6 | 6 | 22 | 29 |
SEl-Q | 8 | 13 | 9 | 12 | 19 | 17 | 2 | 2 | 21 | 19 |
TSST-1 | 0 | 1 | 4 | 10 | 1 | 9 | 0 | 5 | 1 | 14 |
etA | 0 | 0 | 3 | 8 | 0 | 9 | 0 | 3 | 0 | 11 |
etB | 0 | 0 | 3 | 6 | 0 | 8 | 0 | 1 | 0 | 9 |
lukS-PVL | 0 | 2 | 2 | 4 | 2 | 5 | 0 | 3 | 2 | 8 |
lukF-PV | 0 | 0 | 3 | 8 | 0 | 5 | 0 | 6 | 0 | 11 |
lukE-lukD | 0 | 0 | 2 | 4 | 0 | 6 | 0 | 0 | 0 | 6 |
edinA | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
edinB | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
edinC | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
mecA | 49 | 12 | 67 | 32 | 61 | 99 | 0 | 0 | 61 | 99 |